Patients whose tumors expressed survivin in the cytoplasm moderately possessed a 5.7-fold increased risk of tumor-related death (P = 0.004) compared to patients with tumors, that showed a weak expression of survivin (Table 2; Fig. 2A). This evidence concerns the gene BIRC5 and neoplasm.